References
Ammirati E, Frigerio M, Adler ED et al (2020) Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 13(11):e007405. https://doi.org/10.1161/circheartfailure.120.007405.
Ammirati E, Moslehi JJ (2023) Diagnosis and treatment of acute myocarditis: a review. JAMA 329(13):1098–1113. https://doi.org/10.1001/jama.2023.3371
Ammirati E, Cipriani M, Moro C et al (2018) Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy Registry. Circulation 138(11):1088–1099. https://doi.org/10.1161/CIRCULATIONAHA.118.035319
Kociol RD, Cooper LT, Fang JC et al (2020) Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 141(6):e69–e92. https://doi.org/10.1161/cir.0000000000000745.
Ammirati E, Veronese G, Brambatti M et al (2019) Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 74(3):299–311. https://doi.org/10.1016/j.jacc.2019.04.063.
Kondo T, Okumura T, Shibata N et al (2022) Differences in prognosis and cardiac function according to required percutaneous mechanical circulatory support and histological findings in patients with fulminant myocarditis: insights from the CHANGE PUMP 2 study. J Am Heart Assoc 11(4):e023719. https://doi.org/10.1161/jaha.121.023719.
Kanaoka K, Onoue K, Terasaki S et al (2022) Features and outcomes of histologically proven myocarditis with fulminant presentation. Circulation 146(19):1425–1433. https://doi.org/10.1161/circulationaha.121.058869.
Nunez J, Grandin EW, Reyes-Castro T et al (2023) Outcomes with peripheral venoarterial extracorporeal membrane oxygenation for suspected acute myocarditis: 10-year experience from the ELSO Registry. Circ Heart Fail. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010152
Tschöpe C, Van Linthout S, Klein O et al (2019) Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts. J Cardiovasc Transl Res 12(2):116–123. https://doi.org/10.1007/s12265-018-9820-2.
Ammirati E, Buono A, Moroni F et al (2022) State-of-the-art of endomyocardial biopsy on acute myocarditis and chronic inflammatory cardiomyopathy. Curr Cardiol Rep 24(5):597–609. https://doi.org/10.1007/s11886-022-01680-x.
Bennett MK, Gilotra NA, Harrington C et al (2013) Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000–2009. Circ Heart Fail 6(4):676–684. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000087
van der Boon RMA, den Dekker WK, Meuwese CL et al (2021) Safety of endomyocardial biopsy in new-onset acute heart failure requiring veno-arterial extracorporeal membrane oxygenation. Circ Heart Fail 14(8):e008387. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008387
Caforio AL, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648. https://doi.org/10.1093/eurheartj/eht210.
Singh V, Mendirichaga R, Savani GT et al (2018) Comparison of utilization trends, indications, and complications of endomyocardial biopsy in native versus donor hearts (from the nationwide inpatient sample 2002 to 2014). Am J Cardiol 121(3):356–363. https://doi.org/10.1016/j.amjcard.2017.10.021
Ammirati E, Bizzi E, Veronese G et al (2022) Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis. Front Med (Lausanne) 9:838564. https://doi.org/10.3389/fmed.2022.838564.
Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E (2017) Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol 70(19):2363–2375. https://doi.org/10.1016/j.jacc.2017.09.023.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
EA received a grant from the Italian Ministry of Health (GR-2019-12368506; principal investigator of the investigator-driven MYTHS [Myocarditis Therapy with Steroids] trial) and a grant from Italian Ministry of Health and NextGenerationEU (PNRR-MAD-2022-12376225) and is a consultant for Kiniksa and Cytokinetics. EV received speaking fees from Abiomed, Cytokinetics (speaking fees), Abbott, Novo Nordisk). AC reports grants from Getinge, and personal fees from Getinge, Baxter and Xenios outside the submitted work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ammirati, E., Vorovich, E. & Combes, A. Myocarditis: a primer for intensivists. Intensive Care Med 49, 1123–1126 (2023). https://doi.org/10.1007/s00134-023-07143-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-023-07143-3